Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.71 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.71 |
| ▸ | GAA | P10253 | 2/20 | 0.71 |
| ▸ | TUBB4A | P04350 | 2/20 | 0.70 |
| ▸ | TUBB | P07437 | 2/20 | 0.70 |
| ▸ | TUBA3C | P0DPH7 | 2/20 | 0.70 |
| ▸ | TUBA1B | P68363 | 2/20 | 0.70 |
| ▸ | TUBA4A | P68366 | 2/20 | 0.70 |
| ▸ | TUBB4B | P68371 | 2/20 | 0.70 |
| ▸ | TUBB3 | Q13509 | 2/20 | 0.70 |
| ▸ | TUBB2A | Q13885 | 2/20 | 0.70 |
| ▸ | TUBB8 | Q3ZCM7 | 2/20 | 0.70 |
| ▸ | TUBA3E | Q6PEY2 | 2/20 | 0.70 |
| ▸ | TUBA1A | Q71U36 | 2/20 | 0.70 |
| ▸ | TUBA1C | Q9BQE3 | 2/20 | 0.70 |
| ▸ | TUBB6 | Q9BUF5 | 2/20 | 0.70 |
| ▸ | TUBB2B | Q9BVA1 | 2/20 | 0.70 |
| ▸ | TUBB1 | Q9H4B7 | 2/20 | 0.70 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.66 |
| ▸ | PKM | P14618 | 2/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29134048 | 0.95 | MAPT (0.64) | MAPTKDM4EGAATUBB4ATUBB | |
| SCHEMBL22361649 | 0.92 | MAPT (0.65) | MAPTKDM4EGAATUBB4ATUBB | |
| Calycopterin SCHEMBL2214965 | 0.90 | KDM4E (0.73) | MAPTKDM4EGAATUBB4ATUBB | |
| SCHEMBL30049379 | 0.89 | MAPT (0.62) | MAPTKDM4EGAATUBB4ATUBB | |
| SCHEMBL28655626 | 0.89 | MAPT (0.65) | MAPTKDM4EGAATUBB4ATUBB | |
| SCHEMBL4129003 | 0.88 | MAPT (0.85) | MAPTKDM4EGAATUBB4ATUBB | |
| SCHEMBL31558901 | 0.88 | MAPT (0.85) | MAPTKDM4EGAATUBB4ATUBB | |
| SCHEMBL28998302 | 0.88 | MAPT (0.63) | MAPTKDM4EGAATUBB4ATUBB | |
| SCHEMBL1764438 | 0.85 | ALDH1A1 (0.67) | MAPTKDM4EGAATUBB4ATUBB | |
| SCHEMBL28984281 | 0.84 | ALDH1A1 (0.66) | MAPTKDM4EGAATUBB4ATUBB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118121649-A | Citrus extract, compound, and use thereof for inhibiting novel coronaviruses | 丰苗生物科技股份有限公司 | 2024-06-04 | — | — | CN | claimed |
| CN-118121589-A | Compounds and their use for inhibiting novel coronaviruses | 丰苗生物科技股份有限公司 | 2024-06-04 | — | — | CN | claimed |
| CN-118010094-A | Liquid phase analysis method for multiple chemical components in Xinhui dried orange peel | 江门市五邑中医院 | 2024-05-10 | — | — | CN | claimed |
| CN-116660543-A | Diagnostic and prognostic markers for nonalcoholic fatty liver disease and uses thereof | 中国人民解放军陆军军医大学第一附属医院 | 2023-08-29 | — | — | CN | claimed |
| JP-2009506057-A | — | — | 2009-02-12 | — | — | JP | claimed |
| EP-1928480-A2 | METHODS FOR MANAGING ADIPOCYTE FAT ACCUMULATION | Wellgen, Inc. (US) | 2008-06-11 | — | — | EP | claimed |
| WO-2007024982-A2 | METHODS FOR MANAGING ADIPOCYTE FAT ACCUMULATION | WELLGEN, INC. (US) | 2007-03-01 | — | — | WO | claimed |
| CN-118121589-A | Compounds and their use for inhibiting novel coronaviruses | 丰苗生物科技股份有限公司 | 2024-06-04 | — | — | CN | disclosed |
| CN-118121649-A | Citrus extract, compound, and use thereof for inhibiting novel coronaviruses | 丰苗生物科技股份有限公司 | 2024-06-04 | — | — | CN | disclosed |
| CN-118121589-A | Compounds and their use for inhibiting novel coronaviruses | 丰苗生物科技股份有限公司 | 2024-06-04 | — | — | CN | disclosed |
| CN-118010094-A | Liquid phase analysis method for multiple chemical components in Xinhui dried orange peel | 江门市五邑中医院 | 2024-05-10 | — | — | CN | disclosed |
| CN-116609419-A | Method for rapidly identifying core production area of pericarpium citri reticulatae | 佛山科学技术学院 | 2023-08-18 | — | — | CN | disclosed |
| EP-3010499-A1 | COMPOSITIONS COMPRISING AT LEAST ONE POLYMETHOXYFLAVONE, FLAVONOID, LIMINOID, AND/OR TOCOTRIENOL USEFUL IN COMBINATION THERAPIES FOR TREATING DIABETES | KGK Synergize, Inc. (CA) | 2016-04-27 | — | — | EP | disclosed |
| WO-2014203059-A1 | COMPOSITIONS COMPRISING AT LEAST ONE POLYMETHOXYFLAVONE, FLAVONOID, LIMINOID, AND/OR TOCOTRIENOL USEFUL IN COMBINATION THERAPIES FOR TREATING DIABETES | KGK SYNERGIZE, INC. (CA) | 2014-12-24 | — | — | WO | disclosed |
| EP-1928480-A2 | METHODS FOR MANAGING ADIPOCYTE FAT ACCUMULATION | Wellgen, Inc. (US) | 2008-06-11 | — | — | EP | disclosed |
| WO-2007024982-A2 | METHODS FOR MANAGING ADIPOCYTE FAT ACCUMULATION | WELLGEN, INC. (US) | 2007-03-01 | — | — | WO | disclosed |